InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.13
(
0.97%
)
US TECH 100
19,560.00
(
-0.06%
)
Dow Jones
42,080.37
(
0.30%
)
Brent Oil
76.76
(
-0.76%
)
Bitcoin
62,099.12
(
-0.05%
)
Post# of 253309
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120547
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: BTH post# 185353

Monday, 04/20/2015 1:29:40 PM

Monday, April 20, 2015 1:29:40 PM

Post# of 253309
TLOG +14% on clinical collaboration with MRK’s Keytruda:

http://finance.yahoo.com/news/tetralogic-merck-collaborate-evaluation-birinapant-120000330.html

TetraLogic Pharmaceuticals Corporation…and Merck…announced today they have entered into an oncology clinical study collaboration. The companies will collaborate on a Phase 1 study to evaluate the safety and efficacy of birinapant, TetraLogic’s SMAC-mimetic, in combination with KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in patients with relapsed or refractory solid tumors. The study is expected to begin in late 2015.

This is yet another I-O clinical collaboration in which no cash is changing hands.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up